MARKET

AXSM

AXSM

Axsome Therapeut
NASDAQ
181.02
-3.16
-1.72%
Opening 12:40 04/15 EDT
OPEN
184.18
PREV CLOSE
184.18
HIGH
185.05
LOW
179.58
VOLUME
207.11K
TURNOVER
--
52 WEEK HIGH
191.50
52 WEEK LOW
96.09
MARKET CAP
9.26B
P/E (TTM)
-49.1622
1D
5D
1M
3M
1Y
5Y
1D
Axsome Is Priced For Perfection Ahead Of Auvelity's Alzheimer's Agitation Decision
Seeking Alpha · 2d ago
Weekly Report: what happened at AXSM last week (0406-0410)?
Weekly Report · 2d ago
Axsome Therapeutics Is Maintained at Buy by UBS
Dow Jones · 5d ago
UBS Maintains Buy on Axsome Therapeutics, Raises Price Target to $259
Benzinga · 5d ago
AXSOME THERAPEUTICS INC <AXSM.O>: UBS RAISES TARGET PRICE TO $259 FROM $251
Reuters · 5d ago
Axsome Therapeutics price target raised to $259 from $251 at UBS
TipRanks · 5d ago
U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-Hannifin
Reuters · 5d ago
Jefferies Sticks to Its Buy Rating for Axsome Therapeutics (AXSM)
TipRanks · 6d ago
More
About AXSM
Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the developing medicines for people impacted by central nervous system (CNS) conditions. Its commercial products include Auvelity, Sunosi and Symbravo. It is also advancing pipeline of novel product candidates in early- to late-stage development addressing a broad range of serious neurological and psychiatric conditions. Its product pipelines include AXS-05, AXS-12, AXS-14 and AXS-17. Its lead product candidate, AXS-05 (dextromethorphan and bupropion), is developed for the treatment of Alzheimer’s disease (AD) agitation and smoking cessation. Its AXS-12 (reboxetine) is a novel, oral, potent, highly selective investigational norepinephrine reuptake inhibitor (NRI) and cortical dopamine modulator being developed for the treatment of narcolepsy. It also owns balipodect, a novel, oral, potent, and selective phosphodiesterase 10A (PDE10A) inhibitor for the treatment of schizophrenia and Tourette syndrome.

Webull offers Axsome Therapeutics Inc stock information, including NASDAQ: AXSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXSM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXSM stock methods without spending real money on the virtual paper trading platform.